Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$102,194,355
+$30,633,767 QoQ
Shares Held
3,973,342
+6.6% QoQ
Ownership
2.49%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,496,892 across 520 Biotechnology names. DNLI ranks #46 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,194,355 | 3,973,342 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $71,560,588 | 3,727,114 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,093,742 | 3,458,131 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $50,327,147 | 3,466,057 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $44,380,546 | 3,172,305 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $41,290,406 | 3,037,176 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $59,821,066 | 2,935,283 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $86,093,044 | 2,955,477 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $69,254,532 | 2,982,538 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $56,627,669 | 2,759,633 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $57,068,492 | 2,659,296 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $52,231,756 | 2,531,835 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $68,412,944 | 2,318,297 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $49,447,802 | 2,146,172 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $57,009,304 | 2,049,957 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $54,510,473 | 1,776,164 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $50,224,678 | 1,706,581 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $52,467,564 | 1,630,947 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $72,647,468 | 1,628,867 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $81,093,027 | 1,607,394 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $118,995,127 | 1,517,021 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $71,536,707 | 1,252,832 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $96,734,591 | 1,154,902 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $38,916,002 | 1,086,129 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $26,137,371 | 1,080,950 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $17,203,907 | 982,519 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||